ProMIS Neurosciences (PMN) said Monday that the US Food and Drug Administration granted Fast Track designation to its lead candidate PMN310 for treating Alzheimer's disease.
Shares more than doubled as intraday trading volume catapulted to over 268.2 million from a daily average of roughly 1.7 million.
ZimVie (ZIMV) said it agreed to be acquired and taken private by healthcare-focused investment firm Archimed for about $730 million.
Shares of ZimVie surged 122% as intraday trading volume climbed to more than 8.9 million from a daily average of about 146,000.
The Ether Machine (ETHM) announced Monday its public launch through a business combination between The Ether Reserve and Dynamix (DYNX).
Shares of Dynamix advanced nearly 16% as intraday trading volume soared to more than 22.2 million from a daily average of about 22,000.
Price: 1.10, Change: +0.66, Percent Change: +149.94
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。